RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ALIM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Alimera Sciences stock downgraded to Sell Candidate
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

No changes to the price of Alimera Sciences stock on the last trading day (Thursday, 28th Mar 2024). During the last trading day the stock fluctuated 6.65% from a day low at $3.76 to a day high of $4.01. The price has risen in 5 of the last 10 days but is still down by -2.01% for this period.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -2.75% during the next 3 months and, with a 90% probability hold a price between $3.11 and $4.08 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ALIM Signals & Forecast

The Alimera Sciences stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $3.94. On a fall, the stock will find some support from the long-term average at approximately $3.74. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, March 15, 2024, and so far it has fallen -7.36%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Alimera Sciences stock

Alimera Sciences finds support from accumulated volume at $3.89 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.250 between high and low, or 6.65%. For the last week, the stock has had daily average volatility of 5.45%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ALIM) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Alimera Sciences to open at $3.89, and during the day (based on 14 day Average True Range), to move between $3.66 and $4.14, which gives a possible trading interval of +/-$0.241 (+/-6.18%) up or down from last closing price. If Alimera Sciences takes out the full calculated possible swing range there will be an estimated 12.36% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.89 (0.26%) than the resistance at $3.99 (2.31%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Alimera Sciences stock A Buy?

Alimera Sciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.115 Sell Candidate Downgraded

Predicted Opening Price for Alimera Sciences of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$3.89 ( 0.256%) $3.90

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ALIM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.14 6.15 %
R2 4.04 3.71 %
R1 3.99 2.19 %
Current price: 3.90
Support S1 3.79 -2.71 %
S2 3.74 -4.22 %
S3 3.64 -6.67 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 4.21 7.95 %
R2 4.08 4.62 %
R1 3.99 2.31 %
Current price 3.90
Support S1 3.89 -0.256%
S2 3.87 -0.769%
S3 3.34 -14.36%

FAQ

What is the symbol for Alimera Sciences Stock and on which exchange is it traded?
The symbol for Alimera Sciences is ALIM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Alimera Sciences Stock?
Alimera Sciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Alimera Sciences Stock?
Alimera Sciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Alimera Sciences Stock.

What's the current price of Alimera Sciences Stock?
As of the end of day on the 2024-03-28, the price of an Alimera Sciences (ALIM) share was $3.90.

What is the 52-week high and low for Alimera Sciences Stock?
The 52-week high for Alimera Sciences Stock is $4.38 and the 52-week low is $1.56.

What is the market capitalization of Alimera Sciences Stock?
As of the 2024-03-28, the market capitalization of Alimera Sciences is 204.182M.

When is the next earnings date for Alimera Sciences?
The upcoming earnings date for Alimera Sciences is May 20, 2024.
Click to get the best stock tips daily for free!

About Alimera Sciences

Alimera Sciences Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affectin... ALIM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT